Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Prevalence of and Risk Factors for Hcv Among Incarcerated People at Great Tehran Prison: A Cross-Sectional Study Publisher Pubmed



Seyedalinaghi S1 ; Farhoudi B2 ; Shahmohamadi E1 ; Rasoolinejad M1 ; Hasannezhad M1 ; Rashidi MR1 ; Dadras O3 ; Moradi A1 ; Parmoon Z1 ; Ebrahimi H1 ; Asadollahiamin A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Social Determinants of Health Research Center, Amir-al-Momenin Hospital, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  3. 3. Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway

Source: International Journal of Prisoner Health Published:2023


Abstract

Purpose: Hepatitis C is one of the major health issues in both developed and developing countries. Hepatitis C virus (HCV) infection is more common in prisoners than in the general population. The purpose of this study was to determine the prevalence of HCV and its associated risk factors in Iranian male prisoners in Tehran. Design/methodology/approach: In this cross-sectional study, the authors investigated the frequency and risk factors of hepatitis C infection among male prisoners in the Great Tehran Prison. Information on risk factors including the length of imprisonment, previous history of imprisonment, history of drug injection, history of tattooing, history of piercing, history of high-risk sex and family history of hepatitis C were extracted from patients’ records. To evaluate HCV status, blood samples were collected and tested. Findings: In this study, 179 participants were included. Nine participants (5.0%, 95% CI, 2.3-9.3) were positive for hepatitis C. HCV infection was not significantly associated with age, marital status, education, previous history of imprisonment, length of imprisonment, piercing and high-risk sex; however, there was a significant association between a history of tattooing and a history of injecting drug use and Hepatitis C. Originality/value: The prevalence of hepatitis C among male prisoners in Great Tehran Prison was 5% in this study, similar to recent studies on prisoners in Tehran. A history of drug injections as well as tattooing were the most important risk factors for hepatitis C in male prisoners. © 2023, Emerald Publishing Limited.
Related Docs
View other Related Docs
1. Hepatitis B Virus Infection Among People Who Use Drugs in Iran: A Systematic Review, Meta-Analysis, and Trend Analysis, Harm Reduction Journal (2020)
2. An Intervention to Increase Hepatitis C Virus Diagnosis and Treatment Uptake Among People in Custody in Iran, International Journal of Drug Policy (2021)
3. A Simple Risk-Based Strategy for Hepatitis C Virus Screening Among Incarcerated People in a Low- to Middle-Income Setting, Harm Reduction Journal (2020)
4. High Hepatitis C Virus Prevalence Among Drug Users in Iran: Systematic Review and Meta-Analysis of Epidemiological Evidence (2001-2012), International Journal of Infectious Diseases (2015)
5. Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran, Hepatitis Monthly (2017)
6. Prevalence of Drug Injection, Sexual Activity, Tattooing, and Piercing Among Prison Inmates, Epidemiologic Reviews (2018)
7. Public Health Risks Associated With Methadone in Iran: A Systematic Review and Meta-Analysis, International Journal of Drug Policy (2022)
8. Occult Hcv and Occult Hbv Coinfection in Iranian Human Immunodeficiency Virus-Infected Individuals, Journal of Medical Virology (2020)
Experts (# of related papers)
View all Related Experts
Hossein Poustchi (6)
Afarin Rahimi-Movaghar (6)
Other Related Docs
9. Correlates of Injecting Paraphernalia Sharing Among Male Drug Injectors in Kermanshah, Iran: Implications for Hcv Prevention, Journal of Substance Use (2020)
10. Hiv Prevention Cascades for Injection and Sexual Risk Behaviors Among Hiv-Negative People Who Inject Drug in Iran, International Journal of Drug Policy (2020)
11. Patterns of Drug Use and Related Factors Among Prisoners in Iran: Results From the National Survey in 2015, Journal of Primary Prevention (2020)
12. Prevalence and Associated Factors of Hiv Infection Among Male Prisoners in Tehran, Iran, Archives of Iranian Medicine (2017)
13. An Intervention to Improve Hcv Testing, Linkage to Care, and Treatment Among People Who Use Drugs in Tehran, Iran: The Enhance Study, International Journal of Drug Policy (2019)
14. Hiv Prevalence Among Non-Injecting People Who Use Drugs and Related Factors in Iran: A Systematic Review and Meta-Analysis, Drug and Alcohol Review (2022)
15. Seroprevalence of Hepatitis B Virus and Hepatitis C Virus Infections Among People With Severe Mental Illness in Tehran, Iran, Hepatitis Monthly (2022)
16. Continuum of Hepatitis C Care Cascade in Prison and Following Release in the Direct-Acting Antivirals Era, Harm Reduction Journal (2020)
17. Prevalence of Sexually Transmitted Infections and Associated Risk Behaviors in Prisoners: A Systematic Review, Health Science Reports (2022)
18. Factors Influencing Engagement and Utilisation of Opium Tincture-Assisted Treatment for Opioid Use Disorder: A Qualitative Study in Tehran, Iran, Drug and Alcohol Review (2022)
19. Single-Pill Sofosbuvir and Daclatasvir for Treating Hepatis C in Patients Co-Infected With Human Immunodeficiency Virus, International Journal of Clinical Practice (2021)
20. An Overview of the Action Plans of the Islamic Republic of Iran Toward Elimination of Viral Hepatitis B and C, Journal of Mazandaran University of Medical Sciences (2023)
21. Global Prevalence and Genotype Distribution of Hepatitis C Virus Infection in 2015: A Modelling Study, The Lancet Gastroenterology and Hepatology (2017)
22. Prevalence of Hepatitis C Virus Infection Among High-Risk Groups in Iran: A Systematic Review and Meta-Analysis, Public Health (2018)